Dr. Erlinda M Gordon, MD
Claim this profileSarcoma Oncology Research Center
Studies Sarcoma
Studies Soft Tissue Sarcoma
5 reported clinical trials
6 drugs studied
Area of expertise
1Sarcoma
Stage III
Stage IV
2Soft Tissue Sarcoma
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Erlinda M Gordon, MD is currently running
Trabectedin + Immunotherapy
for Soft Tissue Sarcoma
This is an open label, dose-seeking phase 1/2 study using escalating doses of TRABECTEDIN given intravenously with defined doses of IPILIMUMAB and NIVOLUMAB based on preliminary results of the Checkmate 012 trial for NSCLC (Hellman et al., 2016). For the Phase 1 Part of Study, only previously treated patients will be enrolled. For the Phase 2 Part of Study, previously untreated patients will be enrolled.
Recruiting1 award Phase 1 & 2
Lurbinectedin + Immunotherapy
for Soft Tissue Sarcoma
This is an open label, dose-seeking phase 1/2 study using escalating doses of LURBINECTEDIN administered intravenously with fixed doses of IPILIMUMAB and NIVOLUMAB administered intravenously.
Recruiting1 award Phase 1 & 2
More about Erlinda M Gordon, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Erlinda M Gordon, MD has experience with
- Nivolumab
- DeltaRex-G
- Lurbinectedin
- Trabectedin
- Ipilimumab
- Nab-Rapamycin
Breakdown of trials Erlinda M Gordon, MD has run
Sarcoma
Soft Tissue Sarcoma
Chordoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erlinda M Gordon, MD specialize in?
Erlinda M Gordon, MD focuses on Sarcoma and Soft Tissue Sarcoma. In particular, much of their work with Sarcoma has involved Stage III patients, or patients who are Stage IV.
Is Erlinda M Gordon, MD currently recruiting for clinical trials?
Yes, Erlinda M Gordon, MD is currently recruiting for 2 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that Erlinda M Gordon, MD has studied deeply?
Yes, Erlinda M Gordon, MD has studied treatments such as Nivolumab, DeltaRex-G, Lurbinectedin.
What is the best way to schedule an appointment with Erlinda M Gordon, MD?
Apply for one of the trials that Erlinda M Gordon, MD is conducting.
What is the office address of Erlinda M Gordon, MD?
The office of Erlinda M Gordon, MD is located at: Sarcoma Oncology Research Center, Santa Monica, California 90403 United States. This is the address for their practice at the Sarcoma Oncology Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.